Global Cytomegalovirus Retinitis Market 2014-2018

世界のサイトメガロウイルス網膜炎治療市場(2014-2018)

◆タイトル:Global Cytomegalovirus Retinitis Market 2014-2018
◆商品コード:IRTNTR3926
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2014年8月13日
◆ページ数:52
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥280,000見積依頼/購入/質問フォーム
Five UserUSD2,800 ⇒換算¥313,600見積依頼/購入/質問フォーム
Enterprise License(社内共有可)USD3,500 ⇒換算¥392,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

本調査レポートでは、"世界のサイトメガロウイルス網膜炎治療市場(2014-2018)"について調査・分析し、エグゼクティブサマリー、市場概観、市場規模及び予測、投与経路(ROA)別分析、主要地域別分析、市場シェア、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析等の情報をお届けいたします。

About Cytomegalovirus Retinitis
Cytomegalovirus retinitis is a viral eye inflammation of the retina. The causative organism of this disease is cytomegalovirus, a herpes virus that attacks the photosensitive cells in the retina. This disease can lead to permanent blindness if left untreated. It affects one eye initially but spreads to the other eye if neglected. The virus is very commonly found in humans but stays dormant. It usually affects a person with weakened immune system such as HIV-positive patients. There are two forms of cytomegalovirus retinitis: indolent form and fulminant form. Some of the common symptoms of cytomegalovirus retinitis are blurred vision, seeing floaters, photophobia, and blind spots.

TechNavio’s analysts forecast the Global Cytomegalovirus Retinitis market to grow at a CAGR of 4.50 percent over the period 2013-2018.

Covered in this Report
This report covers the present scenario and the growth prospects of the Global Cytomegalovirus Retinitis market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various branded and generic drugs used for the treatment of cytomegalovirus retinitis. Capsules, implants, solutions, and tablets are the four dosage forms of the drugs used for the treatment of cytomegalovirus retinitis.
TechNavio’s report, the Global Cytomegalovirus Retinitis market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Cytomegalovirus Retinitis market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions
• Americas
• APAC
• EMEA

Key Vendors
• F. Hoffmann-La Roche
• Gilead Sciences
• Hospira
• Shire

Other Prominent Vendors
• Auritec Pharmaceuticals
• Chimerix Pharmaceuticals
• Isis Pharmaceuticals
• pSivida
• Sanofi

Market Driver
• Presence of Unmet Needs
• For a full, detailed list, view our report
Market Challenge
• Lack of Approved Treatment Guidelines by the World Health Organization
• For a full, detailed list, view our report
Market Trend
• Increase in Combination Therapies
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【資料の目次】

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
03.2.1 Product Profiles
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Route of Administration
07.1.1 Systemic
07.1.2 Ocular
08. Market Segmentation by Dosage Form
08.1.1 Capsule
08.1.2 Implant
08.1.3 Solution
08.1.4 Tablet
09. Market Assessment of Valcyte
10. Rate of Incidence and Prevalence
11. Geographical Segmentation
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Trends and their Impact
19. Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Market Share Analysis 2013
19.3 Other Prominent Vendors
20. Key Vendor Analysis
20.1 Hospira
20.1.1 Business Overview
20.1.2 Business Segmentation
20.1.3 Key Information
20.1.4 SWOT Analysis
20.2 Gilead Sciences
20.2.1 Business Overview
20.2.2 SWOT Analysis
20.3 Roche
20.3.1 Business Overview
20.3.2 Business Segmentation
20.3.3 Key Information
20.3.4 SWOT Analysis
20.4 Shire
20.4.1 Business Overview
20.4.2 Key Information
20.4.3 SWOT Analysis
21. Other Reports in this Series

List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Cytomegalovirus Retinitis Market 2013-2018 (US$ million)
Exhibit 3: Global Cytomegalovirus Retinitis Market Segmentation by Route of Administration
Exhibit 4: Global Cytomegalovirus Retinitis Market Segmentation by Dosage Form
Exhibit 5: Timeline of Valcyte in the US and EU
Exhibit 6: Quarterly Sales of Valcyte 2013 (US$ million)
Exhibit 7: Quarterly Sales of Valcyte in the US 2013 (US$ million)
Exhibit 8: Quarterly Sales of Valcyte in Europe 2013 (US$ million)
Exhibit 9: Global Cytomegalovirus Retinitis Market by Geographical Segmentation
Exhibit 10: Business Segmentation of Hospira Inc.
Exhibit 11: Business Segmentation of F. Hoffmann La Roche Ltd.



【掲載企業】

F. Hoffmann-La Roche, Gilead Sciences, Hospira, Shire, Auritec Pharmaceuticals, Chimerix Pharmaceuticals, Isis Pharmaceuticals, pSivida and Sanofi



【資料のキーワード】

サイトメガロウイルス網膜炎、CMV網膜炎、治療、治療薬、医薬品

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[世界のサイトメガロウイルス網膜炎治療市場(2014-2018)] (Global Cytomegalovirus Retinitis Market 2014-2018 / IRTNTR3926)販売に関する免責事項
[世界のサイトメガロウイルス網膜炎治療市場(2014-2018)] (Global Cytomegalovirus Retinitis Market 2014-2018 / IRTNTR3926)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆